FDA Approved: URSODIOL — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Ursodiol (URSODIOL) submitted by BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Gallstone Disease

Drugs mentioned

• URSODIOL (ursodiol)

Snippet

SUPPL AP for URSODIOL (URSODIOL)